These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5854635)

  • 21. [Evaluation of selected parameters of blood coagulation and the fibrinolysis system in patients undergoing total hip replacement].
    Sokołowska B; Piecuch W; Walter-Croneck A; Dmoszyńska A; Furmanik F
    Przegl Lek; 2002; 59(7):502-8. PubMed ID: 12516238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of hydroxyethyl starch on hemostasis.
    Cheng C; Lerner B; Lichtenstein S; Karlson KE; Garzon AA
    Surg Forum; 1966; 17():48-50. PubMed ID: 5921022
    [No Abstract]   [Full Text] [Related]  

  • 23. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
    Kudrjashov BA; Pastorova VE; Lyapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Physiology of blood coagulation and fibrinolysis: biochemistry].
    Preissner KT
    Hamostaseologie; 2008 Dec; 28(5):259-71. PubMed ID: 19132158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. State of investigations on hydroxyethylstarch.
    Lutz H; Hartung HJ
    Acta Anaesthesiol Belg; 1984; 35 Suppl():21-6. PubMed ID: 6083692
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass.
    Tabuchi N; de Haan J; Boonstra PW; van Oeveren W
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):828-33. PubMed ID: 8231204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethanol impairs coagulation and fibrinolysis in whole blood: a study performed with rotational thromboelastometry.
    Engström M; Schött U; Reinstrup P
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):661-5. PubMed ID: 17102653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma expanders and bleeding times.
    HORVATH SM; HAMILTON LH; SPURR GB; ALLBAUGH EB; HUTT BK
    J Appl Physiol; 1955 May; 7(6):614-6. PubMed ID: 14381337
    [No Abstract]   [Full Text] [Related]  

  • 30. [Responses to surgical stress in blood coagulation and fibrinolysis, platelet counts and thromboxane B2 after esophageal cancer operation].
    Shinohara M; Kurokawa H; Yoshihara Y; Kokubu S; Kusano T; Horie K; Murakami N; Nagai K; Nara N
    Rinsho Byori; 1997 Feb; 45(2):179-84. PubMed ID: 9121003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of ellagic acid and heparin on coagulation, fibrinolysis and metastasis in traumatized animals (author's transl)].
    Agostino D; Agostino N
    Sangre (Barc); 1980; 25(6):989-98. PubMed ID: 7221832
    [No Abstract]   [Full Text] [Related]  

  • 32. [Activation of coagulation and fibrinolysis in patients with abdominal true aortic aneurysm associated with disseminated intravascular coagulation].
    Akaike M; Yokoi K; Wada M; Sebe T; Shigekiyo T; Kawai H; Saito S
    Kokyu To Junkan; 1993 Mar; 41(3):267-70. PubMed ID: 8469833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The test of heparin tolerance "in vitro"].
    FORTEZA BOVER G; PERIS MORA R; TORMO ALFONSO V; ALGARRA VIDAL F
    Rev Clin Esp; 1960 Oct; 79():38-44. PubMed ID: 13700898
    [No Abstract]   [Full Text] [Related]  

  • 34. Titre of anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems.
    Chilver-Stainer L; Lämmle B; Alberio L
    Thromb Haemost; 2004 Feb; 91(2):276-82. PubMed ID: 14961154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clot formation and gelatin-based plasma substitutes.
    Ruttmann TG; James MF; Viljoen JF
    Lancet; 1996 Nov; 348(9036):1249-50. PubMed ID: 8898067
    [No Abstract]   [Full Text] [Related]  

  • 36. [Activation of fibrinolysis in plasmacoagulum by heparin].
    HALSE T
    Arch Int Pharmacodyn Ther; 1951 Apr; 86(2):168-76. PubMed ID: 14838623
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fibrinolysis and heparin].
    OLIVIER C
    Mem Acad Chir (Paris); 1951 Jan 10-24; 77(1-3):35-6. PubMed ID: 14826475
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experimental study of blood composition influenced by simultaneous replacement with various solutions for depletion. 2. Changes observed on white blood cell count, white blood cell differentials, platelets count, coagulation and bleeding time].
    HARASHIMA S
    Iryo; 1961 Jul; 15():521-7. PubMed ID: 13904547
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacodynamics of blood substitutes].
    From AA
    Probl Gematol Pereliv Krovi; 1969 Sep; 14(9):3-5. PubMed ID: 5376278
    [No Abstract]   [Full Text] [Related]  

  • 40. [The heparin in vitro test in cardiovascular diseases].
    REMY A; PERNOT C; PERNOT M; MULLER Y
    Rev Med Nancy; 1954 May; 79(1-15):289-302. PubMed ID: 13178385
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.